These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 20413761)

  • 1. Prostate tissue composition and MR measurements: investigating the relationships between ADC, T2, K(trans), v(e), and corresponding histologic features.
    Langer DL; van der Kwast TH; Evans AJ; Plotkin A; Trachtenberg J; Wilson BC; Haider MA
    Radiology; 2010 May; 255(2):485-94. PubMed ID: 20413761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2--sparse versus dense cancers.
    Langer DL; van der Kwast TH; Evans AJ; Sun L; Yaffe MJ; Trachtenberg J; Haider MA
    Radiology; 2008 Dec; 249(3):900-8. PubMed ID: 19011187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of Histopathologic Tissue Composition to Quantitative MR Spectroscopy and Diffusion-weighted Imaging of the Prostate.
    Kobus T; van der Laak JA; Maas MC; Hambrock T; Bruggink CC; Hulsbergen-van de Kaa CA; Scheenen TW; Heerschap A
    Radiology; 2016 Mar; 278(3):801-11. PubMed ID: 26418614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI.
    Langer DL; van der Kwast TH; Evans AJ; Trachtenberg J; Wilson BC; Haider MA
    J Magn Reson Imaging; 2009 Aug; 30(2):327-34. PubMed ID: 19629981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findings.
    Mazaheri Y; Shukla-Dave A; Hricak H; Fine SW; Zhang J; Inurrigarro G; Moskowitz CS; Ishill NM; Reuter VE; Touijer K; Zakian KL; Koutcher JA
    Radiology; 2008 Feb; 246(2):480-8. PubMed ID: 18227542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis.
    Tamada T; Sone T; Jo Y; Yamamoto A; Yamashita T; Egashira N; Imai S; Fukunaga M
    Radiology; 2008 Aug; 248(2):531-9. PubMed ID: 18539890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI in the detection of prostate cancer: combined apparent diffusion coefficient, metabolite ratio, and vascular parameters.
    Riches SF; Payne GS; Morgan VA; Sandhu S; Fisher C; Germuska M; Collins DJ; Thompson A; deSouza NM
    AJR Am J Roentgenol; 2009 Dec; 193(6):1583-91. PubMed ID: 19933651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of prostate DCE-MRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue.
    Lowry M; Zelhof B; Liney GP; Gibbs P; Pickles MD; Turnbull LW
    Invest Radiol; 2009 Sep; 44(9):577-84. PubMed ID: 19668002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection--a multireader study.
    Lim HK; Kim JK; Kim KA; Cho KS
    Radiology; 2009 Jan; 250(1):145-51. PubMed ID: 19017927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion-weighted MR imaging in laryngeal and hypopharyngeal carcinoma: association between apparent diffusion coefficient and histologic findings.
    Driessen JP; Caldas-Magalhaes J; Janssen LM; Pameijer FA; Kooij N; Terhaard CH; Grolman W; Philippens ME
    Radiology; 2014 Aug; 272(2):456-63. PubMed ID: 24749712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of diffusion-weighted magnetic resonance data with cellularity in prostate cancer.
    Zelhof B; Pickles M; Liney G; Gibbs P; Rodrigues G; Kraus S; Turnbull L
    BJU Int; 2009 Apr; 103(7):883-8. PubMed ID: 19007373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transition zone prostate cancer: detection and localization with 3-T multiparametric MR imaging.
    Hoeks CM; Hambrock T; Yakar D; Hulsbergen-van de Kaa CA; Feuth T; Witjes JA; Fütterer JJ; Barentsz JO
    Radiology; 2013 Jan; 266(1):207-17. PubMed ID: 23143029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer.
    Hambrock T; Somford DM; Huisman HJ; van Oort IM; Witjes JA; Hulsbergen-van de Kaa CA; Scheenen T; Barentsz JO
    Radiology; 2011 May; 259(2):453-61. PubMed ID: 21502392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis.
    Oto A; Yang C; Kayhan A; Tretiakova M; Antic T; Schmid-Tannwald C; Eggener S; Karczmar GS; Stadler WM
    AJR Am J Roentgenol; 2011 Dec; 197(6):1382-90. PubMed ID: 22109293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of aggressiveness of prostate cancer: correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy.
    Verma S; Rajesh A; Morales H; Lemen L; Bills G; Delworth M; Gaitonde K; Ying J; Samartunga R; Lamba M
    AJR Am J Roentgenol; 2011 Feb; 196(2):374-81. PubMed ID: 21257890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology.
    Selnæs KM; Heerschap A; Jensen LR; Tessem MB; Schweder GJ; Goa PE; Viset T; Angelsen A; Gribbestad IS
    Invest Radiol; 2012 Nov; 47(11):624-33. PubMed ID: 23011187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla.
    Gibbs P; Liney GP; Pickles MD; Zelhof B; Rodrigues G; Turnbull LW
    Invest Radiol; 2009 Sep; 44(9):572-6. PubMed ID: 19692841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging.
    Engelbrecht MR; Huisman HJ; Laheij RJ; Jager GJ; van Leenders GJ; Hulsbergen-Van De Kaa CA; de la Rosette JJ; Blickman JG; Barentsz JO
    Radiology; 2003 Oct; 229(1):248-54. PubMed ID: 12944607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer: comparison of tumor visibility on trace diffusion-weighted images and the apparent diffusion coefficient map.
    Rosenkrantz AB; Kong X; Niver BE; Berkman DS; Melamed J; Babb JS; Taneja SS
    AJR Am J Roentgenol; 2011 Jan; 196(1):123-9. PubMed ID: 21178056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of prostatitis and prostate cancer by using diffusion-weighted MR imaging and MR-guided biopsy at 3 T.
    Nagel KN; Schouten MG; Hambrock T; Litjens GJ; Hoeks CM; ten Haken B; Barentsz JO; Fütterer JJ
    Radiology; 2013 Apr; 267(1):164-72. PubMed ID: 23329653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.